Get started
Author

И. Г. Починка

Observed names: I G Pochinka, I. G. Pochinka, I. G. Pochinka, I. Pochinka, I.G. Pochinka, Il'ya Grigor'evich Pochinka, Ilya G. Pochinka, Ilya Pochinka, И.Г. Починка
ORCID: 0000-0001-5709-0703
Observed ORCID: 0000-0001-5709-0703
OpenAlex ID: A5077220755
Clinical features of post-COVID-19 period. Results of the international register “Dynamic analysis of comorbidities in SARS-CoV-2 survivors (AKTIV SARS-CoV-2)”. Data from 6-month follow-up
2021 · G. P. Arutyunov, E. I. Tarlovskaya, et al. · Russian Journal of Cardiology · 62
PDF
Contemporary Management of Severe Symptomatic Aortic Stenosis
2021 · Marc Eugène, Piotr Duchnowski, et al. · Journal of the American College of Cardiology · 56
PDF
International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV SARS-CoV-2): analysis of predictors of short-term adverse outcomes in COVID-19
2021 · G. P. Arutyunov, E. I. Tarlovskaya, et al. · Russian Journal of Cardiology · 56
PDF
International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV) and the register “Analysis of hospitalizations of comorbid patients infected during the second wave of SARS-CoV-2 outbreak” (AKTIV 2)
2021 · G. P. Arutyunov, E. I. Tarlovskaya, et al. · Russian Journal of Cardiology · 26
PDF
Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)
2021 · E. I. Tarlovskaya, A. G. Arutyunov, et al. · Kardiologiia · 21
ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis
2022 · Gregory P. Arutyunov, Ekaterina I. Tarlovskaya, et al. · Terapevticheskii arkhiv · 18
PDF
Coronary microvascular obstruction (the no-reflow phenomenon) during percutaneous coronary interventions in patients with myocardial infarction
2020 · A. Frolov, I. Pochinka, et al. · Patologiya krovoobrashcheniya i kardiokhirurgiya · 14
PDF
Clinical features of post-COVID period. Results of an International Register "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors (ACTIV SARS-CoV-2)" (12-month follow-up)
2022 · G. P. Arutyunov, E. I Tarlovskaya, et al. · Russian Journal of Cardiology · 12
PDF
Newly diagnosed diseases and the frequency of their occurrence in patients after a new coronavirus infection. Results of an International Register "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors (ACTIV SARS-CoV-2)" (12-month follow-up)
2023 · G. P. Arutyunov, E. I. Tarlovskaya, et al. · Russian Journal of Cardiology · 10
PDF
Effect of Type 2 Diabetes Mellitus on Five‑Year Survival of Patients Hospitalized Because of Acute Decompensated Heart Failure
2017 · I. G. Pochinka, L. G. Strongin, et al. · Kardiologiia · 7
PDF
The impact of BMI on the course of the acute SARS-COV-2 infection and the risks that emerge during the first year after the hospital discharge. Subanalysis evidence of the AKTIV and AKTIV 2 registries
2023 · A. G. Arutyunov, E. I. Tarlovskaya, et al. · Problems of Endocrinology · 6
PDF
Using an Artificial Neural Network to Predict Coronary Microvascular Obstruction (No-Reflow Phenomenon) during Percutaneous Coronary Interventions in Patients with Myocardial Infarction
2021 · A.A. Frolov, I.G. Pochinka, et al. · Современные технологии в медицине · 5
PDF
Lipid profile in hospitalized patients with COVID-19 depending on the outcome of its acute phase: data from the international registry "Dynamics analysis of comorbidities in SARS-CoV-2 infection survivors"
2022 · G. P. Arutyunov, E. I. Tarlovskaya, et al. · Russian Journal of Cardiology · 4
PDF
Glycemia in patients with type 2 diabetes during inpatient treatment for acute myocardial infarction: impact on prognosis
2021 · M. A. Korotina, I. G. Pochinka, et al. · Russian Journal of Cardiology · 4
PDF
Phenotypes of coronary microvascular obstruction phenomenon (no-reflow) during percutaneous coronary interventions in myocardial infarction
2024 · A. A. Frolov, I. A. Frolov, et al. · Bulletin of Siberian Medicine · 3
PDF
Use of metformin in patients with type 2 diabetes and acute myocardial infarction: safety and impact on glycemic control
2023 · M. A. Korotina, I. G. Pochinka, et al. · Problems of Endocrinology · 3
PDF
Effect of late culprit coronary artery revascularization on prognosis of patients with ST-elevation myocardial infarction
2020 · A. A. Frolov, K. V. Kuzmichev, et al. · Russian Journal of Cardiology · 3
PDF
Diabetes mellitus and hospital mortality at myocardial infarction. Data of the hospital register of acute coronary syndrome
2018 · L.G. Strongin, А.V. Bushueva, et al. · Medical Almanac · 3
Glycemic control on development of chronic heart failure in patients with type 2 diabetes mellitus
2012 · Leonid Grigor'evich Strongin, Il'ya Grigor'evich Pochinka, et al. · Diabetes Mellitus · 3
PDF
Genetic characteristics of patients with left ventricular remodeling after ST-segment elevation myocardial infarction
2025 · K. V. Kuzmichev, I. G. Pochinka, et al. · Russian Journal of Cardiology · 2
Coronary microvascular obstruction in percutaneous coronary interventions in myocardial infarction patients: a comprehensive approach to prevention and treatment
2024 · A.A. Frolov, I.G. Pochinka, et al. · Patologiya krovoobrashcheniya i kardiokhirurgiya · 2
PDF
[Variability of glycemia and ventricular rhythm disturbances in patients with chronic heart failure and type 2 diabetes mellitus].
2013 · I G Pochinka, L G Strongin, et al. · PubMed · 2
Genetic Scale for Predicting the No-Reflow Phenomenon in Myocardial Infarction
2025 · I.G. Pochinka, A.A. Frolov, et al. · Современные технологии в медицине · 1
PDF
Acetazolamide per os in Decompensated Chronic Heart Failure: Randomized Multicenter Trial ORION-A
2025 · Ibragim Sabirov, Olesya Rubanenko, et al. · Journal of Clinical Medicine · 1
PDF
Prognostic value of no-reflow phenomenon in myocardial infarction: the role of the severity of ischemic damage
2024 · A. A. Frolov, M. G. Kashtanov, et al. · Russian Journal of Cardiology · 1
PDF
Works count: 57
Citation count: 332
H-index: 9
I10-index: 9
Year
Topic
Type